Place it in its market
Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.
See how Context works →On the price, the facts of the public record■Insider buy□Insider sell◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account
End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.
Latest on record
The most recent facts, as filed.
Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.
- Sep 9, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
- Aug 18, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
- Aug 17, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
In numbers
What this profile holds, counted.
Closes · 1 year250
SEC filings on record6324 flagged findings
Reported transactions (Form 4)45since Apr 4, 2023 · and 1 other holding
Corporate events (8-K)30since Jun 8, 2020
What the record says
Description, identity and filings, each with its source.
Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.
Reverse splits in 5 years
1 reverse split in 5 years (1:12 on Oct 11, 2022) · 1:12 cumulative
The other times: of 818 securities that did their first reverse split in 5 years, a year later the median was worth 0.53× the price on the day of the split; 382 lost more than half and 209 rose (809 with a price a year later).
Our own series, not the whole market: based on the splits we have on record (provider and SEC); an unrecorded one does not count. Historical distribution, not a prediction.
The 25 most recent filings (of 632)
Every SEC filing, newest first, with what it is. Below, each type with its own explanation.
- Sep 9, 268-K ↗Current report · Communication to the market
- Aug 21, 26Form 3 ↗Insider transaction
- Aug 18, 268-K ↗Current report · A senior executive left or was appointed
- Aug 17, 268-K ↗Current report · Communication to the market
- Aug 13, 2610-Q ↗Quarterly report
- Aug 7, 26SCHEDULE 13D/A ↗Stake with intent to influence · Phillip Frost, M.D. · 13.9% · event on Aug 3, 26 · amendment
- Aug 7, 26SCHEDULE 13D ↗Stake with intent to influence · OPKO HEALTH, INC. · 29.6% · event on Jul 31, 26
- Aug 3, 268-K ↗Current report · Sold unregistered shares
- Jul 17, 268-K ↗Current report · Shareholder vote results
- Jun 9, 268-K ↗Current report · A senior executive left or was appointed
- Jun 3, 26Form 4 ↗Insider transaction
- Jun 3, 26Form 3 ↗Insider transaction
- Jun 3, 268-K ↗Current report · Communication to the market
- May 27, 26DEFA14A ↗Shareholder meeting and votes
- May 27, 26DEF 14A ↗Shareholder meeting and votes
- May 26, 268-K ↗Current report · Communication to the market
- May 15, 2610-Q ↗Quarterly report
- Apr 30, 268-K ↗Current report · Communication to the market
- Apr 29, 26CORRESP ↗Correspondence with the SEC
- Apr 28, 26UPLOAD ↗Correspondence with the SEC
- Apr 23, 26S-3 ↗Securities offering
- Apr 2, 268-K ↗Current report · Communication to the market
- Mar 31, 2610-K ↗Annual report
632 filings on record, the oldest from Oct 9, 07.
Listing the 25 most recent filings of the 632 on record.
108147
- Aug 18, 26A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Aug 3, 26Sold unregistered shares+3 more in the same filing8-K 3.02 ↗
3 senior executive changes2026show all 3hide
- Jun 9, 26A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Mar 13, 26A senior executive left or was appointed8-K 5.02 ↗
- Jan 15, 26A senior executive left or was appointed8-K 5.02 ↗
- Oct 30, 25Sold unregistered shares+3 more in the same filing8-K 3.02 ↗
- Sep 15, 25Entered a material agreement+3 more in the same filing8-K 1.01 ↗
- Apr 8, 25A senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
- Oct 10, 24A senior executive left or was appointed8-K 5.02 ↗
- Mar 1, 24A material agreement was terminated+1 more in the same filing8-K 1.02 ↗
- Dec 21, 23A material agreement was terminated+1 more in the same filing8-K 1.02 ↗
- Apr 24, 23A senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
- Apr 10, 23Sold unregistered shares+3 more in the same filing8-K 3.02 ↗
- Oct 26, 22Listing notice (8-K 3.01)+2 more in the same filing8-K 3.01 ↗
12 older filings not shown · The record reaches back to Mar 30, 10.
Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.
- May 19, 22Listing notice (8-K 3.01)8-K 3.01 ↗
- Nov 19, 21Listing notice (8-K 3.01)8-K 3.01 ↗
- Nov 6, 20Listing notice (8-K 3.01)8-K 3.01 ↗
- Dec 16, 19Listing notice (8-K 3.01)8-K 3.01 ↗
- Sep 28, 12Past accounts declared unreliable and being restated+1 more in the same filing8-K 4.02 ↗
- Aug 17, 12Past accounts declared unreliable and being restated+1 more in the same filing8-K/A 4.02 ↗
- Aug 13, 12Past accounts declared unreliable and being restated+1 more in the same filing8-K 4.02 ↗
- Nov 3, 11A debt obligation was accelerated+3 more in the same filing8-K 2.04 ↗
- Aug 18, 11A debt obligation was accelerated8-K 2.04 ↗
The full record holds 10 stress filings.
Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.
Schedule 13D: stake and stated purpose
Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.
- OPKO HEALTH, INC.29.6%Jul 31, 26SCHEDULE 13D ↗4 co-filers on this document — the figure is the largest single stake, not their sum.
- Phillip Frost, M.D.13.9%Aug 3, 26SCHEDULE 13D/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.
- Aug 5, 26Buy$10KPHILLIP MD ET AL FROST↗
- Aug 3, 26Buy$71KPHILLIP MD ET AL FROST↗
- Feb 24, 26Buy$20KPHILLIP MD ET AL FROST↗
- Feb 6, 26Buy$47KPHILLIP MD ET AL FROST↗
- Dec 31, 25Buy$47KPHILLIP MD ET AL FROST↗
- Dec 30, 25Buy$19KPHILLIP MD ET AL FROST↗
- Dec 26, 25Buy$39KPHILLIP MD ET AL FROST↗
- Dec 24, 25Buy$24KPHILLIP MD ET AL FROST↗
- Nov 26, 25Buy$2KPHILLIP MD ET AL FROST↗
- Nov 26, 25Buy$2KPHILLIP MD ET AL FROST↗
- Nov 25, 25Buy$19KPHILLIP MD ET AL FROST↗
- Apr 4, 23Buy$2.0MPHILLIP MD ET AL FROST↗
Stock compensation, tax and giftsshow the 12 other transactionshide
Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.
- Oct 28, 25Compensation$5KJames Joseph MartinCo-CEO and CFO↗
- Oct 28, 25Compensationamount n/aRICHARD C PFENNIGER JR↗
- Oct 28, 25Compensation$500KFred Hassan↗
- Oct 28, 25Compensation$500KPHILLIP MD ET AL FROST↗
- Oct 9, 24Compensationamount n/aAnthony J Japour↗
- Oct 9, 24Compensationamount n/aFred Hassan↗
- Oct 9, 24Compensationamount n/aJames Joseph MartinCo-CEO and CFO↗
- Oct 9, 24Compensationamount n/aPHILLIP MD ET AL FROST↗
- Oct 9, 24Compensationamount n/aRICHARD C PFENNIGER JR↗
- Oct 9, 24Compensationamount n/aRoger D. Kornberg↗
- Oct 9, 24Compensationamount n/aSam LeePresident and Co-CEO↗
- Oct 9, 24Compensationamount n/aSteven D Rubin↗
The full record holds 24 transactions and goes back to Apr 4, 23.
Its sector and its market
Cocrystal Pharma Inc. among Health Care companies
The profile shows what is on record. Context and Radar place the company among those of its sector and region.
Browse its neighbours
Other Health Care companies
With an account you also get
- The four engines — growth, trend, risk and context — each with its word and its score.
- The risk band and the sector phase.
- The company's fundamentals and accounts.
- Watchlist: your list of companies, with the «since you follow it» figure.
The research continues
The profile tells the story. The market sets the scene.
From Cocrystal Pharma Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.
See what deserves a closer look
Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.
See how Radar works →Keep the why
Follow Cocrystal Pharma Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.
See an example review →
Coverage
What sits behind this page.
Where each figure comes from and how far it reaches.
- Prices
- End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
- Series quality
- Series with incidents in the period; the chart shows what could be kept.
- SEC records
- 632 documents on file, from Oct 9, 2007 to Sep 9, 2026.
- Company description
- No description available.
- This page
- Generated on Oct 19, 2026; refreshed through the day.
Start at your own pace
Explore first. Go deeper with access.
Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.
Compare plans →- No account
This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.
- Pro
What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.
- Pro+
Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.
Are the prices real time?
No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.
Which SEC documents appear here?
Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.
Why does a European company show no SEC records?
It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.
Before forming a view on a company,
read what is on record.
One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.